Web8 dec. 2024 · Mahana Therapeutics, Inc. 230 California Street, Suite 302 . San Francisco, CA 94111 . United States . More Press Releases Mahana Therapeutics Obtains CE … WebFounded Date 2009. Operating Status Active. Legal Name Makana Therapeutics, Inc. Company Type For Profit. Makana Therapeutics is focused on developing swine with …
Mahana raises $61m funding for digital therapeutics - NS Medical …
WebIn this episode we hear from Simon Levy, CEO and Co-founder, and Ann Montgomery, Chief Product Officer at Mahana. In their own words, Mahana develops digital treatments for people living with chronic health conditions, and their first treatment, Mahana for IBS, is now available as an FDA-cleared app. Webcomputerized behavioral therapy device for treating symptoms. 22. De Novo Number. DEN200029. Device Name. Parallel. Requester. Mahana Therapeutics, Inc. 230 … stephen doheny cricket
Digital-Treatments Startup Mahana Therapeutics Gathers $61 …
WebMahana Therapeutics Sep 2024 - Present1 year 8 months Senior Consultant- Behavioral Economics/ Science Self Employed Jan 2024 - Present5 years 4 months United States … WebView Justin Zamirowski at Mahana on The Org. View Justin Zamirowski at Mahana on The Org. Explore. Iterate. Vision. Log in. Sign up. Mahana. Justin Zamirowski; ... Chief Commercial Officer (CCO) at Galera Therapeutics. The Org helps you hire great candidates. It takes less than ten minutes to set up your company page. It’s free to use - … Web7 sep. 2024 · Five out (reSET, reSET-O, Somryst, NightWare and EndeavorRx) of the seven therapeutic applications (authorized in the United States and Japan), targeted the neuropsychiatric disorders; Parallel (targets IBS, a gastrointestinal disorder) and the CASC system (targets nicotine dependence, a respiratory disorder). stephen doherty